IDH1: Linking Metabolism and Epigenetics
Mutations in genes encoding enzymes of the tricarboxylic acid cycle often contribute to cancer development and progression by disrupting cell metabolism and altering the epigenetic landscape. This is exemplified by the isoforms of isocitrate dehydrogenase (IDH1/2), which metabolize isocitrate to α-K...
Main Authors: | Silvia Raineri, Jane Mellor |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2018.00493/full |
Similar Items
-
Recent advances of IDH1 mutant inhibitor in cancer therapy
by: Wangqi Tian, et al.
Published: (2022-08-01) -
2-HG Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 Promoter
by: Zhentao Yang, et al.
Published: (2017-05-01) -
Vorasidenib in IDH1/2-mutant low-grade glioma: the grey zone of patient’s selection
by: Lidia Gatto, et al.
Published: (2024-01-01) -
IDH1: Linking metabolism and epigenetics
by: Raineri, S, et al.
Published: (2018) -
IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives
by: Mondesir J, et al.
Published: (2016-09-01)